Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet's disease-related uveitis: a case report.

Chika ToriuKinya TsubotaYoshihiko UsuiHiroshi Goto

Published in: Journal of ophthalmic inflammation and infection (2023)

This case suggests that in patients with BD who have discontinued anti-TNF therapy due to miliary TB, restarting anti-TNF therapy may be a therapeutic option after TB has been treated appropriately with careful monitoring for relapse.

Keyphrases

rheumatoid arthritis
mycobacterium tuberculosis
emergency department
juvenile idiopathic arthritis
bone marrow
pulmonary tuberculosis
hiv aids
electronic health record
systemic lupus erythematosus
antiretroviral therapy